
How to Lift the Skin Without the Unwanted Facial Fat Loss
Date
Written by
Rana Bassal
Revised by
Amy Lewis, MD
The aesthetic industry is undergoing a huge shift. Patients aren't just worried about wrinkles anymore; they're intensely focused on skin sagging and overall facial structure.
This trend is being turbo-charged by the popularity of new weight loss medications (GLP-1s). Suddenly, a huge wave of new aesthetic patients is walking into clinics, and their number one complaint isn't surface wrinkles - it's skin laxity and dramatic volume loss from the rapid weight change.
For clinicians, this means the rules have changed: successful facial rejuvenation must focus on strengthening the skin while aggressively minimizing the risk of unintended fat loss. If a treatment could cause volume change, it may now be counterproductive. This is why precise, dermal-focused technology like Sofwave is becoming the indispensable solution.

The Hidden Hazard of Unwanted Facial Fat Loss:
While some procedures (such as cryolipolysis or certain body contouring devices) intentionally target fat, when volume disappears prematurely or unintentionally from the face, it can dramatically accelerate the signs of aging.
The Problem with Deep Heat: High-Intensity Risks
Many popular aesthetic procedures that deliver heat to deeper tissue layers carry a risk of causing fat cell damage (necrosis or atrophy).
RF Microneedling (RFMN): The risk here is real and recognized by the FDA. The U.S. Food and Drug Administration has issued a safety communication detailing serious adverse events linked to certain RF microneedling uses, including fat loss, burns, scarring, and nerve damage. These problems often stem from delivering heat too deeply or at high settings, particularly in delicate areas like the cheeks. The FDA is clear: RF microneedling is a medical procedure, not a simple cosmetic treatment, and shouldn't be used at home.

High-Intensity Focused Ultrasound (HIFU): Older focused ultrasound devices were associated with complications like pain, nerve injury, skin burns, and fat atrophy because they targeted the deepest tissue layers.
The Market is Moving Away from Fat Destruction
The industry itself is clearly signaling a shift. Data from the International Society of Aesthetic Plastic Surgery (ISAPS) shows that the desire for fat destruction devices has "completely fallen off the radar," with a 40% drop in demand from 2023 to 2024.
This dramatic shift is being echoed across the clinical community. Leading practitioners are publicly discussing the need for safer, more predictable options. For example, prominent expert Dr. Jimmy Sung recently posted a commentary, highlighting the crucial difference between deep fat-targeting devices and the new generation of dermal-focused technology. This public, real-world discussion reinforces the data—the future is in volume-sparing technology.
What's growing? Demand for non-invasive skin lifting, which jumped by 39% during the same period. The focus is now on structural support, not subtraction.
SOFWAVE: Safe Skin Regeneration That Protects Volume
The Sofwave device was specifically engineered to address this new market need: target the dermal layer for collagen production while actively sparing underlying structures, including facial fat.
Mechanism of Action: Precise & Parallel Energy
Sofwave uses Synchronous Ultrasound Parallel Beam (SUPERB™) Technology to generate high-intensity, high-frequency, parallel ultrasound beams.
Mid-Dermal Focus is the Key: These parallel beams ensure the thermal effect is perfectly localized between 0.5-2 mm within the dermis, with the primary focus at a depth of 1.5 mm. This layer is rich in collagen and elastin, which the treatment aims to remodel.
Rapid Thermal Dissipation: The high ultrasound frequency causes thermal energy to dissipate rapidly at depths greater than 2 mm. This is the crucial safety feature.

What Makes SOFWAVE Immune to Fat Loss
Sofwave's design successfully avoids the structures that typically lead to fat atrophy or nerve damage associated with other devices:
Protection of Underlying Structures: Because the energy dissipates so quickly below 2 mm, the high-intensity energy leaves nerves, facial fat, and bones completely unaffected.
Epidermal Protection: The built-in Sofcool™ Technology provides real-time skin temperature feedback, preventing any thermal damage to the epidermis.

The Landscape of Non-Surgical Rejuvenation: A Comparison
When choosing a treatment to stimulate neocollagenesis (new collagen formation), considering targeted depth and risk profile is essential.
| Treatment/Technology | Primary Target Area | Risk of Unintended Facial Fat Loss |
|---|---|---|
| RF Microneedling (RFMN) | Reticular Dermis / Sub-dermis (up to 7mm) | Reported Risk. Associated with fat loss, burns, and nerve damage. |
| High-Intensity Focused Ultrasound (HIFU) | Deep SMAS layer (up to 4.5 mm) | Reported Risk. Earlier devices associated with fat atrophy. |
| Fractional Resurfacing Lasers | Epidermis / Superficial Dermis (<1mm) | Low (Focuses mainly on surface texture). |
| Synchronous Ultrasound Parallel Beam (Sofwave) | Mid-Dermis ONLY (1.5 mm Focus) | None. Engineered to dissipate energy safely above the fat layer. |
Because Sofwave focuses its energy exclusively on the mid-dermis (1.5mm) and avoids deeper, risky layers, it offers a distinct advantage for patients seeking powerful lifting without the risk of unwanted facial volume loss. This makes it uniquely suitable for addressing the skin laxity concerns that are currently driving the modern aesthetic market, especially those arising from rapid weight changes.

References
- Amir, R. (2020). A novel approach to treating fine lines and wrinkles of the face using Synchronous Ultrasound Parallel Beam Technology SUPERB™. (Multi-center clinical study conducted at Laser & Skin Surgery Center of New York and New York Laser & Skin Care). https://api.sofwave.com/app/uploads/2024/12/PB00030-4_White-PaperFINAL.pdf
- Boonchoo, Kanjana & Hongcharu, Wichai. (2025). The Efficacy and Safety of a Single Treatment of High- Intensity, High- Frequency, Non- Focused Ultrasound Parallel Beams for Facial Acne Scars in Asian Patients: A Preliminary Study. Journal of Cosmetic Dermatology. https://api.sofwave.com/app/uploads/2025/04/Dr-Wichai-Article.pdf
- Brown, Ariel B., Rawitscher, Courtney H., & Teller, Craig F. (2025). Neocollagenesis to Reduce Skin Laxity: A Review of the Mechanisms and Efficacies of Modern Devices. Opinion in Progress in Cosmetic Dermatology. https://ascpd.org.au/wp-content/uploads/ascpd-Cosmeceuticals-for-Hyperpigmentation-10.11-Neocollagenesis-to-Reduce-Skin-Laxity.pdf
- Gold, Michael H., & Biron, Julie. (2024). Efficacy and safety of high-intensity, high-frequency, non-focused ultrasound parallel beams for facial skin laxity. Journal of Cosmetic Dermatology. (Published January 2024). https://pubmed.ncbi.nlm.nih.gov/38031530/
- Hongcharu, W., Boonchoo, K., & Gold, M. H. (2023). The efficacy and safety of the high-intensity parallel beam ultrasound device at the depth of 1.5 mm for skin tightening. Journal of Cosmetic Dermatology. https://ascpd.org.au/wp-content/uploads/ascpd-Cosmeceuticals-for-Hyperpigmentation-10.11-Neocollagenesis-to-Reduce-Skin-Laxity.pdf
- Levy, Tal, Lerman, Ilana, Waibel, Jill, et al. (2025). Expert Consensus on Clinical Recommendations for Fractional Ablative CO2 Laser, in Facial Skin Rejuvenation Treatment. Lasers in Surgery and Medicine. (This source contains information regarding complementary treatments like neuromodulators, IPL, HIFU/RF, and fillers, and the effectiveness of fractional ablative resurfacing). https://vbn.aau.dk/files/769162620/Levy_et_al._2025_._Expert_Consensus_on_Clinical_Recommendations_for_Fractional_Ablative_CO2_Laser_in_Facial_Skin_Rejuvenation_Treatment.pdf
- McKinsey & Company Life Sciences Practices Report (Published May 2025). (Cited for data that 63% of GLP-1 patients seeking aesthetic services are new to the market and skin laxity is their primary concern). https://www.investing.com/news/transcripts/earnings-call-transcript-sofwave-medical-q2-2025-shows-strong-revenue-growth-93CH-4170665
- Sofwave Medical Ltd. Earnings Call Transcript Q2 2025. (Cites data from ISAPS Global Survey showing demand for energy-based fat destruction devices is off by 40% from 2023 to 2024, and demand for skin tightening grew by 39%). https://www.investing.com/news/transcripts/earnings-call-transcript-sofwave-medical-q2-2025-shows-strong-revenue-growth-93CH-4170665
- SkyQuest Technology Consulting Pvt. Ltd. (May 2025). Medical Aesthetics Market Size, Share, and Growth Analysis, Industry Forecast 2025-2032. (Cited for market growth rates and forecast size to USD 49.2 billion by 2032). https://www.investing.com/news/transcripts/earnings-call-transcript-sofwave-medical-q2-2025-shows-strong-revenue-growth-93CH-4170665
- U.S. Food and Drug Administration (FDA) Safety Communication (Date Issued: October 15, 2025). Potential Risks with Certain Uses of Radiofrequency (RF) Microneedling. (Cited for warnings regarding serious complications including fat loss, burns, scarring, disfigurement, and nerve damage). https://www.fda.gov/medical-devices/safety-communications/potential-risks-certain-uses-radiofrequency-rf-microneedling-fda-safety-communication




